Biocom
Based in CA
🤖
AI Overview
With $2.1M in lobbying spend across 34 quarterly filings, Biocom is a significant lobbying presence. Their lobbying covers 11 issue areas. Active from 2018 to 2025.
$2.1M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
11
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $184K |
| 2019 | $213K |
| 2020 | $250K |
| 2021 | $180K |
| 2022 | $300K |
| 2023 | $300K |
| 2024 | $300K |
| 2025 | $375K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Taxation, Copyright/Patent, Energy and 6 more
- •Hosted an advocacy fly-in about regenerative medicine
- •Discussed how the life science community can help address the opioid crisis
- •Supported expanded coverage of whole-genome sequencing
- •Advocated for
- •Advocated for increased funding for NIH and FDA in FY2018 omnibus.
- •Advocated for the suspension of the medical device tax.
- •Advocated for reforms of IPR proceedings at the PTAB, including support of the STRONGER Patents Act
- •Advocated for increased funding for NIH and FDA in FY2019 appropriations.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.